TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer

Shinako Araki, Jacob A. Eitel, Christopher N. Batuello, Khadijeh Bijangi-Vishehsaraei, Xian Jin Xie, David Danielpour, Karen E. Pollok, David A. Boothman, Lindsey D. Mayo

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The E3 ubiquitin ligase human murine double minute (HDM2) is overexpressed in 40%-80% of late-stage metastatic cancers in the absence of gene amplification. Hdm2 regulates p53 stability via ubiquitination and has also been implicated in altering the sensitivity of cells to TGF-β1. Whether TGF-β1 signaling induces Hdm2 expression leading to HDM2-mediated destabilization of p53 has not been investigated. In this study, we report that TGF-β1-activated SMA- and MAD3 (Smad3/4) transcription factors specifically bound to the second promoter region of HDM2, leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines. Additionally, TGF-β1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT). Furthermore, histological analyses of human breast cancer samples demonstrated that approximately 65% of late-stage carcinomas were positive for activated Smad3 and HDM2, indicating a strong correlation between TGF-β1-mediated induction of HDM2 and late-stage tumor progression. Identification of Hdm2 as a downstream target of TGF-β1 represents a critical prosurvival mechanism in cancer progression and provides another point for therapeutic intervention in late-stage cancer.

Original languageEnglish (US)
Pages (from-to)290-302
Number of pages13
JournalJournal of Clinical Investigation
Volume120
Issue number1
DOIs
StatePublished - Jan 4 2010

Fingerprint

Breast Neoplasms
Neoplasms
Ubiquitin-Protein Ligases
Epithelial-Mesenchymal Transition
Gene Amplification
Ubiquitination
Genetic Promoter Regions
Breast
Transcription Factors
Epithelial Cells
Carcinoma
Cell Line
Proteins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X. J., Danielpour, D., ... Mayo, L. D. (2010). TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. Journal of Clinical Investigation, 120(1), 290-302. https://doi.org/10.1172/JCI39194

TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. / Araki, Shinako; Eitel, Jacob A.; Batuello, Christopher N.; Bijangi-Vishehsaraei, Khadijeh; Xie, Xian Jin; Danielpour, David; Pollok, Karen E.; Boothman, David A.; Mayo, Lindsey D.

In: Journal of Clinical Investigation, Vol. 120, No. 1, 04.01.2010, p. 290-302.

Research output: Contribution to journalArticle

Araki, S, Eitel, JA, Batuello, CN, Bijangi-Vishehsaraei, K, Xie, XJ, Danielpour, D, Pollok, KE, Boothman, DA & Mayo, LD 2010, 'TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer', Journal of Clinical Investigation, vol. 120, no. 1, pp. 290-302. https://doi.org/10.1172/JCI39194
Araki S, Eitel JA, Batuello CN, Bijangi-Vishehsaraei K, Xie XJ, Danielpour D et al. TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. Journal of Clinical Investigation. 2010 Jan 4;120(1):290-302. https://doi.org/10.1172/JCI39194
Araki, Shinako ; Eitel, Jacob A. ; Batuello, Christopher N. ; Bijangi-Vishehsaraei, Khadijeh ; Xie, Xian Jin ; Danielpour, David ; Pollok, Karen E. ; Boothman, David A. ; Mayo, Lindsey D. / TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. In: Journal of Clinical Investigation. 2010 ; Vol. 120, No. 1. pp. 290-302.
@article{ead62ea7e19a4093bcb5f4378f6133cd,
title = "TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer",
abstract = "The E3 ubiquitin ligase human murine double minute (HDM2) is overexpressed in 40{\%}-80{\%} of late-stage metastatic cancers in the absence of gene amplification. Hdm2 regulates p53 stability via ubiquitination and has also been implicated in altering the sensitivity of cells to TGF-β1. Whether TGF-β1 signaling induces Hdm2 expression leading to HDM2-mediated destabilization of p53 has not been investigated. In this study, we report that TGF-β1-activated SMA- and MAD3 (Smad3/4) transcription factors specifically bound to the second promoter region of HDM2, leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines. Additionally, TGF-β1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT). Furthermore, histological analyses of human breast cancer samples demonstrated that approximately 65{\%} of late-stage carcinomas were positive for activated Smad3 and HDM2, indicating a strong correlation between TGF-β1-mediated induction of HDM2 and late-stage tumor progression. Identification of Hdm2 as a downstream target of TGF-β1 represents a critical prosurvival mechanism in cancer progression and provides another point for therapeutic intervention in late-stage cancer.",
author = "Shinako Araki and Eitel, {Jacob A.} and Batuello, {Christopher N.} and Khadijeh Bijangi-Vishehsaraei and Xie, {Xian Jin} and David Danielpour and Pollok, {Karen E.} and Boothman, {David A.} and Mayo, {Lindsey D.}",
year = "2010",
month = "1",
day = "4",
doi = "10.1172/JCI39194",
language = "English (US)",
volume = "120",
pages = "290--302",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer

AU - Araki, Shinako

AU - Eitel, Jacob A.

AU - Batuello, Christopher N.

AU - Bijangi-Vishehsaraei, Khadijeh

AU - Xie, Xian Jin

AU - Danielpour, David

AU - Pollok, Karen E.

AU - Boothman, David A.

AU - Mayo, Lindsey D.

PY - 2010/1/4

Y1 - 2010/1/4

N2 - The E3 ubiquitin ligase human murine double minute (HDM2) is overexpressed in 40%-80% of late-stage metastatic cancers in the absence of gene amplification. Hdm2 regulates p53 stability via ubiquitination and has also been implicated in altering the sensitivity of cells to TGF-β1. Whether TGF-β1 signaling induces Hdm2 expression leading to HDM2-mediated destabilization of p53 has not been investigated. In this study, we report that TGF-β1-activated SMA- and MAD3 (Smad3/4) transcription factors specifically bound to the second promoter region of HDM2, leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines. Additionally, TGF-β1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT). Furthermore, histological analyses of human breast cancer samples demonstrated that approximately 65% of late-stage carcinomas were positive for activated Smad3 and HDM2, indicating a strong correlation between TGF-β1-mediated induction of HDM2 and late-stage tumor progression. Identification of Hdm2 as a downstream target of TGF-β1 represents a critical prosurvival mechanism in cancer progression and provides another point for therapeutic intervention in late-stage cancer.

AB - The E3 ubiquitin ligase human murine double minute (HDM2) is overexpressed in 40%-80% of late-stage metastatic cancers in the absence of gene amplification. Hdm2 regulates p53 stability via ubiquitination and has also been implicated in altering the sensitivity of cells to TGF-β1. Whether TGF-β1 signaling induces Hdm2 expression leading to HDM2-mediated destabilization of p53 has not been investigated. In this study, we report that TGF-β1-activated SMA- and MAD3 (Smad3/4) transcription factors specifically bound to the second promoter region of HDM2, leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines. Additionally, TGF-β1 expression led to Smad3 activation and murine double minute 2 (Mdm2) expression in murine mammary epithelial cells during epithelial-to-mesenchymal transition (EMT). Furthermore, histological analyses of human breast cancer samples demonstrated that approximately 65% of late-stage carcinomas were positive for activated Smad3 and HDM2, indicating a strong correlation between TGF-β1-mediated induction of HDM2 and late-stage tumor progression. Identification of Hdm2 as a downstream target of TGF-β1 represents a critical prosurvival mechanism in cancer progression and provides another point for therapeutic intervention in late-stage cancer.

UR - http://www.scopus.com/inward/record.url?scp=74949132577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949132577&partnerID=8YFLogxK

U2 - 10.1172/JCI39194

DO - 10.1172/JCI39194

M3 - Article

C2 - 19955655

AN - SCOPUS:74949132577

VL - 120

SP - 290

EP - 302

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -